Cancer medicines
Fulvestrant
Fulvestrant
An injectable hormone therapy that degrades estrogen receptors.
Sources checked · Introductory guide
On this page
How it works
A SERD that binds estrogen receptors, blocks signaling and promotes receptor loss.[4]
Where it is used
Used alone or with targeted medicines in selected hormone receptor-positive advanced breast cancers.[1]
Key safety points
Disclose anticoagulants, bleeding problems and liver disease. Report leg pain, numbness or weakness after injection promptly.[2]
Questions for your care team
- Which targeted medicine is paired with it, and is ovarian suppression needed?
Sources and scope
Source documents are in English.
Entries summarize and translate linked official public sources. The source-check date records when those sources were checked; it does not indicate a clinician’s review.
- NCI · Fulvestrant (opens in a new tab)
- MedlinePlus · Fulvestrant (opens in a new tab)
- NCI Drug Dictionary · Fulvestrant (opens in a new tab)
- NCI · Hormone Therapy for Breast Cancer (opens in a new tab)
General information based on official public sources. This is not a complete list of uses or side effects. Individual treatment decisions require your care team and current source documents. US-source uses do not establish local approval or reimbursement.